> Products > oxalaMic acid ethyl ester

China oxalaMic acid ethyl ester Factory

owing to excellent support, a variety of top of the range items, aggressive rates and efficient delivery, we enjoy a very good reputation among our clients. We have been an energetic firm with wide market for oxalaMic acid ethyl ester,CAS NO 349125-08-2,349125-08-2,Edoxaban intermediate,Edoxaban advance intermediate, We sincerely welcome domestic and foreign merchants who calls, letters asking, or to plants to negotiate, we will offer you quality products and the most enthusiastic service,We look forward to your visit and your cooperation.
oxalaMic acid ethyl ester, If you have any requests, pls email Us with your detailed demands, we are going to offer you the most wholesale Competitive Price with the Super Quality and the Unbeatable First-class Service ! We can offer you the most competitive prices and high quality, because we have been much more Skilled! So remember to do not hesitate to contact us.

Hot Products

4,5-Dihydro-5-Methyl-3,4-diphenyl-5-isoxazolol
Product Name:4,5-Dihydro-5-Methyl-3,4-diphenyl-5-isoxazolol
Molecular Formula:C16H15NO2
Molecular Weight:253.3
CAS Registry Number:181696-73-1
Rhodanine-3-acetic acid
Product Name:Rhodanine-3-acetic acid
Molecular Formula:C5H5NO3S2
Molecular Weight:191.23
CAS Registry Number:5718-83-2
Gadolinium, [10-[2-(hydroxy-kO)-3-hydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-kN1,kN4,kN7,kN10,kO1,kO4,kO7]-,monohydrate,[SA-8-1425362'5'-(R*,S*)]- (9CI)
Product Name:Gadolinium, [10-[2-(hydroxy-kO)-3-hydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-kN1,kN4,kN7,kN10,kO1,kO4,kO7]-,monohydrate,[SA-8-1425362'5'-(R*,S*)]- (9CI)
Molecular Formula:C18H32GdN4O10
Molecular Weight:621.72
CAS Registry Number:198637-52-4
5-PyriMidinecarboxylic acid, 4-[[(3-chloro-4-Methoxyphenyl)Methyl]aMino]-2-[(2S)-2-(hydroxyMethyl)- 1-pyrrolidinyl]-
Product Name:5-PyriMidinecarboxylic acid, 4-[[(3-chloro-4-Methoxyphenyl)Methyl]aMino]-2-[(2S)-2-(hydroxyMethyl)- 1-pyrrolidinyl]-
Molecular Formula:C18H21ClN4O4
Molecular Weight:392.84
CAS Registry Number:330785-84-7
4-Chloro-3-nitro-5-sulphamoylbenzoic acid
Product Name:4-Chloro-3-nitro-5-sulphamoylbenzoic acid
Molecular Formula:C7H5ClN2O6S
Molecular Weight:280.64
CAS Registry Number:22892-96-2
(+/-)-trans-1,2-Diaminocyclohexane
Product Name:(+/-)-trans-1,2-Diaminocyclohexane
Molecular Formula:C6H14N2
Molecular Weight:114.19
CAS Registry Number:1121-22-8

Related Blog
Reviews

Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?
API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.
Development Trend of China's Pharmaceutical Intermediate Industry
The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.
FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC
On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.
What Is Ursodeoxycholic Acid Used For?
Ursodeoxycholic acid is a cholelithiant commonly used in the gastroenterology department, and also a cholelithiasis dissolving agent, so it can be used in the treatment of gallstones under normal circumstances, on the premise...
TOP 8 Linezolid intermediate maker
Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.
What is Coenzyme Q10 CAS NO.303-98-0
Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

China oxalaMic acid ethyl ester Factory

Related Products

Hot Products

4,5-Dihydro-5-Methyl-3,4-diphenyl-5-isoxazolol

Rhodanine-3-acetic acid

Gadolinium, [10-[2-(hydroxy-kO)-3-hydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-kN1,kN4,kN7,kN10,kO1,kO4,kO7]-,monohydrate,[SA-8-1425362'5'-(R,S)]- (9CI)

5-PyriMidinecarboxylic acid, 4-[[(3-chloro-4-Methoxyphenyl)Methyl]aMino]-2-[(2S)-2-(hydroxyMethyl)- 1-pyrrolidinyl]-

4-Chloro-3-nitro-5-sulphamoylbenzoic acid

(+/-)-trans-1,2-Diaminocyclohexane

Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

Development Trend of China's Pharmaceutical Intermediate Industry

FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

What Is Ursodeoxycholic Acid Used For?

TOP 8 Linezolid intermediate maker

What is Coenzyme Q10 CAS NO.303-98-0

Eric 2024-05-22 18:17:05

Letitia 2023-12-25 20:34:00

Juliet 2022-10-17 09:07:24

Christopher Mabey 2023-06-04 10:39:48

Emma 2024-05-25 12:18:16

Octavia 2024-05-01 04:55:09

Send Inquiry